Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic

2011 ◽  
Vol 17 (4) ◽  
pp. 387-394 ◽  
Author(s):  
Megan McKee ◽  
Bradi L Frei ◽  
Anita Garcia ◽  
David Fike ◽  
Scott A Soefje
Keyword(s):  
Clinical Pharmacy ◽  
Demographic Data ◽  
Counseling Services ◽  
Pharmacy Services ◽  
Cross Sectional Survey ◽  
Survey Tool ◽  
Clinical Pharmacy Services ◽  
Medication Therapy ◽  
The Impact

Background. Assessing the role of the pharmacist in an outpatient oncology clinic requires quantification of parameters that are important to the patient and the healthcare system. Patient evaluations not only serve as benchmarks for a process; but may also predict behavior such as utilization of care, continuity with the provider, and compliance. Purpose. To identify the role of the patient–pharmacist relationship and enhance patient satisfaction with care, a survey tool was developed and utilized. Methods. A 20-item, 2-page survey tool was developed and administered to oncology patients actively receiving treatment at the Cancer Therapy & Research Center (CTRC) in San Antonio, Texas. Following approval from the Investigational Review Board, survey distribution began on December 1, 2009 and continued through February 2010. Basic social and demographic data were collected. Satisfaction with pharmacy service was assessed with questions on a Likert ranking scale detailing time spent with pharmacists, knowledge of medication therapy, willingness to pay for clinical pharmacy services, etc. The primary outcome was the impact of the pharmacist–patient relationship assessed by examining the interaction between time spent with pharmacist, understanding of medications, and desire for future pharmacy counseling services. Results. A total of 77 surveys were administered and collected. Of the patients surveyed, 86% stated that it is important for patients to discuss their treatment with a pharmacist and 76% requested pharmacy follow-up at future visits. Conclusion. This cross-sectional survey reveals that patients are interested in visiting with a pharmacist regularly during chemotherapy treatment and patients may be willing to pay for pharmacy counseling services.

scholarly journals PERCEPTIONS OF PHYSICIANS ABOUT CLINICAL PHARMACIST’S ROLE IN AL QASSIM’S HOSPITALS IN SAUDI ARABIA

2017 ◽  
Vol 17 (3) ◽  
pp. 109-116
Author(s):  
Nahid Osman Ahmed ◽  
Mahfoudh A. M. Abdulghani ◽  
Sarah Fahad Alrebdi ◽  
Mohammed Faez Baobaid
Keyword(s):  
Clinical Pharmacy ◽  
Healthcare Professionals ◽  
Response Rate ◽  
Pharmacy Services ◽  
Medication History ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Clinical Pharmacy Services ◽  
Clinical Pharmacists

The objective of this study is to explore physician’s perception toward clinical pharmacy services and role of clinical pharmacists in governmental hospitals at Al-Qassim region. An observational cross-sectional survey was conducted. Results: 150 males and 39 females participated giving 75.5% (189 of 250) response rate. Physicians perceptions were found to be high (equal or more than 90% of frequency) in some clinical pharmacy services such as patients’ education and counselling, monitoring of patients’ responses to drug therapy including toxicity/side effects and provision of drug information to healthcare professionals. The physicians showed low perception (less than 76%) in the taking of patients’ medication history on admission, by clinical pharmacists. Conclusion: Physicians’ perception toward clinical pharmacy services and the role of clinical pharmacists was not found to be completely favourable. The reason of this mixed responses and to the accommodating feelings of clinical pharmacy services in clinical setting appear to relate to the state of infrastructure and environments of hospitals. The infrastructure and environments of hospitals need to be updated for an improved accommodation clinical pharmacy services.

Diabetes: The Impact of Clinical Pharmacy Services Integrated into Medical Homes on Diabetes-Related Clinical Outcomes

2010 ◽  
Vol 44 (12) ◽  
pp. 1877-1886 ◽  
Author(s):  
Kathleen A Johnson ◽  
Steven Chen ◽  
I-Ning Cheng ◽  
Mimi Lou ◽  
Paul Gregerson ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Clinical Pharmacy ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Medical Homes ◽  
The Impact

The impact of clinical pharmacy services in Nepal in the context of current health policy: a systematic review

2019 ◽  
Vol 28 (3) ◽  
pp. 245-255
Author(s):  
Reyaj Mikrani ◽  
Muhammad Naveed ◽  
Aman Mikrani ◽  
Sufia Yasmeen ◽  
MD. Akabar ◽  
...  
Keyword(s):  
Systematic Review ◽  
Health Policy ◽  
Clinical Pharmacy ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Current Health ◽  
The Impact

scholarly journals Hospital-Based Clinical Pharmacy Services to Improve Ambulatory Management of Chronic Obstructive Pulmonary Disease

2016 ◽  
Vol 33 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Amber Lanae Smith ◽  
Valerie Palmer ◽  
Nada Farhat ◽  
James S. Kalus ◽  
Krishna Thavarajah ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Ambulatory Care ◽  
Pulmonary Disease ◽  
Clinical Pharmacy ◽  
Chronic Obstructive ◽  
Pharmacy Services ◽  
Obstructive Pulmonary Disease ◽  
Clinical Pharmacy Services ◽  
Significant Difference ◽  
The Impact

Background: No systematic evaluations of a comprehensive clinical pharmacy process measures currently exist to determine an optimal ambulatory care collaboration model for chronic obstructive pulmonary disease (COPD) patients. Objective: Describe the impact of a pharmacist-provided clinical COPD bundle on the management of COPD in a hospital-based ambulatory care clinic. Methods: This retrospective cohort analysis evaluated patients with COPD managed in an outpatient pulmonary clinic. The primary objective of this study was to assess the completion of 4 metrics known to improve the management of COPD: (1) medication therapy management, (2) quality measures including smoking cessation and vaccines, (3) patient adherence, and (4) patient education. The secondary objective was to evaluate the impact of the clinical COPD bundle on clinical and economic outcomes at 30 and 90 days post–initial visit. Results: A total of 138 patients were included in the study; 70 patients served as controls and 68 patients received the COPD bundle from the clinical pharmacist. No patients from the control group had all 4 metrics completed as documented, compared to 66 of the COPD bundle group ( P < .0001). Additionally, a statistically significant difference was found in all 4 metrics when evaluated individually. Clinical pharmacy services reduced the number of phone call consults at 90 days ( P = .04) but did not have a statistically significant impact on any additional pre-identified clinical outcomes. Conclusion: A pharmacist-driven clinical COPD bundle was associated with significant increases in the completion and documentation of 4 metrics known to improve the outpatient management of COPD.

scholarly journals Analysis on Clinical pharmacy services provided by pharmacists for promoting elderly patients care

2020 ◽  
Vol 11 (SPL4) ◽  
pp. 745-750
Author(s):  
Bushan Kumar GG ◽  
Jyothi Singamsetty ◽  
Rajasekhar K V ◽  
Sahitya Meda
Keyword(s):  
Patient Care ◽  
Adverse Drug Reactions ◽  
Clinical Pharmacy ◽  
Clinical Pharmacist ◽  
Pharmacy Services ◽  
Care Hospital ◽  
Drug Reactions ◽  
Clinical Pharmacy Services ◽  
Medication Therapy ◽  
Prescription Errors

Clinical pharmacy services are the services provided by the pharmacists to promote patient care, optimizes medication therapy, promote health and disease prevention. This prospective cross sectional study was conducted in tertiary care hospital over a period of 6 months. This collected data is checked for their appropriateness of any prescription related errors and DRPs were identified. Results obtained were assessed to determine the influence of Clinical pharmacist services. Majority of the prescriptions were with 5-9(62.5%) drugs. The majority of co-morbidities among 125 enrolled patients in age group of 60-70, 55 patients were with 3-4 co-morbidities. Among 125 prescriptions around 12 prescriptions were identified with 622 drug interactions. Among 125 patients 2 (0.277) adverse drug reactions were observed and according to Naranjo's probability assessment scale these adverse drug reactions were mild and 15(2.08%) dispensing errors, 10(1.386%) prescription errors where majority of prescription errors are due to missed written frequencies in the prescriptions. 5(0.693%) administration errors, 5 (0.693%)untreated indications were observed. Presence of clinical pharmacist in hospital settings can reduce drug related problems and they can assist other staff in improving patient care.

Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction

2020 ◽  
pp. 107815522095041
Author(s):  
Lauren Munro ◽  
Glenn Myers ◽  
Odette Gould ◽  
Michael LeBlanc
Keyword(s):  
Clinical Pharmacy ◽  
Qualitative Data ◽  
Patient Perception ◽  
Mixed Methods Study ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Telephone Interviews ◽  
Patient Interviews ◽  
Ambulatory Oncology

Introduction Studies have shown that patients rate pharmacists more favourably when the pharmacist expresses interest in the patient and attends to patients’ perspectives. There is limited available evidence evaluating both patient perception and satisfaction regarding clinical pharmacy services provided in an ambulatory oncology clinic. Methods This was a prospective mixed methods study involving surveys and patient interviews. Consenting participants completed a survey at their first visit evaluating their perceptions of the importance of the clinical pharmacy services offered in the ambulatory oncology clinic. They completed a second survey 6-8 weeks later to re-evaluate their perceptions and to measure satisfaction ratings. The final component of this study involved semi-structured one-on-one telephone interviews to gather qualitative data regarding the study objectives. Results A total of 35 participants completed the survey, of which eleven completed one-on-one patient telephone interviews. Patients perceived the clinical pharmacy services assessed as important to their care before receiving treatment. The ratings of the importance of the pharmacist in managing patients’ nausea/vomiting significantly decreased when remeasured, whereas the importance of meeting the pharmacist in the clinic significantly increased. The importance of the role of the pharmacist was highlighted in patient interviews as well: patients particularly valued the pharmacist’s initiative to meet them in the clinic, the education provided by pharmacist, and the pharmacist’s accessibility throughout treatment. Conclusions Overall, patients in the ambulatory oncology clinic perceived the services offered as important to their care and they were highly satisfied.

Implementation of Ward-Based Clinical Pharmacy Services in Belgium—Description of the Impact on a Geriatric Unit

2006 ◽  
Vol 40 (4) ◽  
pp. 720-728 ◽  
Author(s):  
Anne Spinewine ◽  
Soraya Dhillon ◽  
Louise Mallet ◽  
Paul M Tulkens ◽  
Léon Wilmotte ◽  
...  
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Geriatric Unit ◽  
The Impact

Pharmacists' roles in oncology pharmacy services: Results of a global survey

2016 ◽  
Vol 23 (3) ◽  
pp. 185-194 ◽  
Author(s):  
Lisa M Holle ◽  
Christy S Harris ◽  
Alexandre Chan ◽  
Rebecca J Fahrenbruch ◽  
Bonnie A Labdi ◽  
...  
Keyword(s):  
Oral Chemotherapy ◽  
Research Network ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Survey Tool ◽  
Medication Therapy ◽  
Education Of Patients ◽  
Level Of Training ◽  
Oncology Practice ◽  
The Impact

Background Oncology pharmacists are capable of providing medication therapy management (MTM) because of their level of training, practice experiences, and responsibilities. Very little data exist about their current practice, including changing roles in the multidisciplinary team, overall impact, and effects in the education of patients and healthcare professionals. Methods A 70-item survey about oncology pharmacists' activities in oral chemotherapy programs, MTM, and collaborative practice agreements (CPAs) was deployed using a web survey tool (Qualtrics, Provo, UT, USA), targeting pharmacist members of American College of Clinical Pharmacy (ACCP) Hematology/Oncology Practice and Research Network (PRN). The objective of this study was to determine oncology pharmacists' activities in areas of oral chemotherapy programs, MTM, and CPAs. A cross-sectional survey was distributed to the ACCP Hematology/Oncology PRN membership. Investigational Review Board approval was obtained. Results Of the 795 members who were sent the survey, 81 members (10%) responded; 33 respondents (47%) are involved with an oral chemotherapy program; with 42% measuring outcomes of programs. Only six pharmacists (19%) have published or presented their data. A total of 28 (35%) respondents provide MTM services, with almost half (43%) of these MTM services being dictated by CPAs. A small fraction of these pharmacists (21.4%) reported conducting quality assurance evaluations of their MTM services and three pharmacists (10.7%) reported publishing their results. Those pharmacists practicing under CPAs ( n = 28) were surveyed as to activities included in their CPA. The most common activities included adjusting medication, ordering, interpreting, and monitoring lab tests, developing therapeutic plans and educating patients. Reimbursement for providing these services was uncommon: MTM (4%), oral chemotherapy program (6%), and CPA services (11%). Reported obstacles to reimbursement included lack of understanding, administrative assistance, or time with setting up reimbursement models within the institution. Conclusion Many oncology pharmacists are participating in oral chemotherapy programs, MTM, and/or CPAs and perceived barriers were identified. Increased efforts should be directed toward prospectively reporting and assessing the impact these services have on patient care.

scholarly journals Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic

2021 ◽  
Vol 27 (3) ◽  
pp. 650-657
Author(s):  
Maria Marchese ◽  
Angela Heintzman ◽  
Mark Pasetka ◽  
Flay Charbonneau ◽  
Carlo DeAngelis ◽  
...  
Keyword(s):  
Clinical Pharmacy ◽  
High Risk Group ◽  
System Level ◽  
Clinical Pharmacy Service ◽  
Pharmacy Services ◽  
Process Maps ◽  
Cancer Centre ◽  
Clinical Pharmacy Services ◽  
Medication Therapy ◽  
Before And After

Virtual methods have been innovatively utilized to provide clinical and supportive care to patients with cancer. Oncology pharmacists have been actively involved in this movement, in order to minimize patient contact and decrease the risk of viral transmission for this high-risk group. In response to COVID-19 restrictions, the Odette Cancer Centre pharmacy modified the delivery of clinical pharmacy services (CPS), including medication histories and patient education/counseling, to a remote telephone-based model. Process maps were created to visualize workflow before and after the pandemic. Process metrics were tracked over a 6-week period. From March 25th to May 1st, 2020, 202 best-possible medication histories and baseline assessments were completed; 149 of these (74%) were completed remotely. For medication therapy counsels, 72 of 199 were completed remotely (36%). Despite workflow disruptions caused by the pandemic, these results demonstrate that clinical pharmacy service levels could be maintained by incorporating remote delivery approaches without significant investment in resources. Challenges included acceptance by patients and lack of technology to support system-level processes. Further research to develop, refine, and individualize virtual clinical pharmacy care models will help to consolidate the role of these approaches in the post-COVID-19 era.

Sign in / Sign up

Export Citation Format

Share Document